Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionProfund Advisors Llc
Latest Disclosed Ownership142,142 shares
Latest Disclosed Value $ 2,055,373
Profund Advisors Llc reports 22.56% decrease in ownership of FOLD / Amicus Therapeutics, Inc.

On April 24, 2026 - Profund Advisors Llc filed a 13F-HR form disclosing ownership of 142,142 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $2,055,373 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 183,552 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -22.56% during the quarter. The current value of the position is $2,059,638 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 142,142 -41,410 -22.56 2,055 -21.35 0.0755
2026-02-06 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 183,552 100,317 120.52 2,614 298.93 0.0794
2025-11-06 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 83,235 -4,442 -5.07 656 30.48 0.0213
2025-08-07 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 87,677 31,997 57.47 502 10.57 0.0181
2025-05-08 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 55,680 -12,113 -17.87 454 -28.84 0.0197
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 67,793 -15,379 -18.49 639 -28.15 0.0233
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 83,172 -3,763 -4.33 888 3.02 0.0336
2024-08-13 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 86,935 -32,323 -27.10 862 -38.60 0.0320
2024-05-08 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 119,258 -13,148 -9.93 1,405 -25.24 0.0547
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 132,406 10,199 8.35 1,879 26.38 0.0807
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 122,207 1,478 1.22 1,486 -1.98 0.0822
2023-08-10 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 120,729 7,288 6.42 1,516 20.51 0.0813
2023-05-12 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 113,441 89,783 379.50 1,258 336.81 0.0777
2023-02-02 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 23,658 1,367 6.13 289 23.61 0.0187
2022-11-07 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 22,291 -349 -1.54 233 -4.12 0.0168
2022-08-01 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 22,640 -351 -1.53 243 11.47 0.0154
2022-05-10 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 22,991 -1,636 -6.64 218 -23.24 0.0092
2022-02-08 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 24,627 1,735 7.58 284 29.68 0.0093
2021-11-12 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 22,892 -4,360 -16.00 219 -16.41 0.0074
2021-08-12 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 27,252 2,371 9.53 262 6.50 0.0088
2021-05-14 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 24,881 1,372 5.84 246 -54.70 0.0095
2021-02-09 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 23,509 1,371 6.19 543 73.48 0.0237
2020-11-13 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 22,138 -1,164 -5.00 313 -10.83 0.0161
2020-08-03 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 23,302 1,571 7.23 351 74.63 0.0195
2020-05-15 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 21,731 -3,078 -12.41 201 -16.94 0.0151
2020-02-18 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 24,809 4,352 21.27 242 47.56 0.0105
2019-11-12 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 20,457 -2,403 -10.51 164 -42.46 0.0083
2019-08-13 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 22,860 2,546 12.53 285 3.26 0.0135
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 20,314 -7,116 -25.94 276 4.94 0.0133
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 27,430 -10,251 -27.20 263 -42.32 0.0163
2018-11-13 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 37,681 37,681 456 0.0173
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.